E
MedX Health Corp MDXHF
$0.0008 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 11/4/2024Downgrade
MedX Health Corp (MDXHF) was downgraded to E+ from D- on 11/4/2024 due to a noticeable decline in the volatility index and growth index.
D
Sell 10/18/2024Upgraded
MedX Health Corp (MDXHF) was upgraded to D- from E+ on 10/18/2024 due to an increase in the volatility index and total return index.
E
Sell 10/3/2024Downgrade
MedX Health Corp (MDXHF) was downgraded to E+ from D- on 10/3/2024 due to a decline in the volatility index, total return index and growth index. Operating cash flow declined 63.92% from -$338.1 to -$554.2, and total revenue declined 3.79% from $79.2 to $76.2.
D
Sell 5/2/2024Upgraded
MedX Health Corp (MDXHF) was upgraded to D- from E+ on 5/2/2024 due to an increase in the total return index and volatility index.
E
Sell 10/24/2023Downgrade
MedX Health Corp (MDXHF) was downgraded to E+ from D- on 10/24/2023 due to a decline in the volatility index and solvency index. The quick ratio declined from 0.11 to 0.04, and debt to equity increased from -0.82 to -0.77.
D
Sell 4/13/2023Upgraded
MedX Health Corp (MDXHF) was upgraded to D- from E+ on 4/13/2023 due to an increase in the total return index and volatility index.
E
Sell 3/14/2023Downgrade
MedX Health Corp (MDXHF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
D
Sell 2/23/2023Upgraded
MedX Health Corp (MDXHF) was upgraded to D- from E+ on 02/23/2023.
E
Sell 2/8/2023Downgrade
MedX Health Corp (MDXHF) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the solvency index, total return index and volatility index.
D
Sell 5/4/2022Upgraded
MedX Health Corp (MDXHF) was upgraded to D- from E+ on 5/4/2022 due to an increase in the growth index and solvency index. Total revenue increased 126.1% from $74.7 to $168.9, operating cash flow increased 33.7% from -$873.6 to -$579.2, and EBIT increased 19.48% from -$1.1M to -$887.6.
E
Sell 4/20/2022Downgrade
MedX Health Corp (MDXHF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell 12/13/2021Downgrade
MedX Health Corp (MDXHF) was downgraded to D- from D on 12/13/2021 due to a noticeable decline in the total return index, growth index and volatility index. Total revenue declined 37.38% from $119.3 to $74.7, earnings per share declined from -$0.0056 to -$0.0068, and EBIT declined 20.92% from -$911.6 to -$1.1M.
D
Sell 11/23/2021Upgraded
MedX Health Corp (MDXHF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell 11/8/2021Downgrade
MedX Health Corp (MDXHF) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index.
D
Sell 6/29/2020Upgraded
MedX Health Corp (MDXHF) was upgraded to D from D- on 6/29/2020 due to an increase in the total return index, valuation index and solvency index.
D
Sell 6/12/2020Downgrade
MedX Health Corp (MDXHF) was downgraded to D- from D on 6/12/2020 due to a major decline in the growth index, solvency index and valuation index. EBIT declined 112.83% from -$409.9 to -$872.4, earnings per share declined from -$0.0031 to -$0.0063, and operating cash flow declined 60.86% from -$128.5 to -$206.7.
D
Sell 5/1/2020Downgrade
MedX Health Corp (MDXHF) was downgraded to D from D+ on 5/1/2020 due to a significant decline in the efficiency index, volatility index and total return index.
D
Sell 4/15/2020Downgrade
MedX Health Corp (MDXHF) was downgraded to D+ from C- on 4/15/2020 due to a substantial decline in the solvency index and valuation index.
C
Hold 3/27/2020Upgraded
MedX Health Corp (MDXHF) was upgraded to C- from D+ on 3/27/2020 due to an increase in the volatility index, growth index and valuation index. Operating cash flow increased 59.58% from -$317.9 to -$128.5, earnings per share increased from -$0.0039 to -$0.0031, and EBIT increased 20.36% from -$514.7 to -$409.9.
D
Sell 10/15/2019Downgrade
MedX Health Corp (MDXHF) was downgraded to D+ from C- on 10/15/2019 due to a decline in the total return index and volatility index.
C
Hold 9/6/2019Upgraded
MedX Health Corp (MDXHF) was upgraded to C- from D+ on 9/6/2019 due to an increase in the growth index and volatility index.
D
Sell 8/29/2019Upgraded
MedX Health Corp (MDXHF) was upgraded to D+ from D on 8/29/2019 due to a significant increase in the efficiency index and growth index. Total revenue increased 39.35% from $139 to $193.7, net income increased 9.06% from -$592.8 to -$539.1, and EBIT increased 8.64% from -$563.4 to -$514.7.
D
Sell 5/31/2019Downgrade
MedX Health Corp (MDXHF) was downgraded to D from C- on 5/31/2019 due to a significant decline in the efficiency index, growth index and total return index. Total revenue declined 33.33% from $208.5 to $139, earnings per share declined from -$0.0057 to -$0.0075, and total capital declined 19.48% from -$740.4 to -$884.6.
C
Hold 8/24/2018Upgraded
MedX Health Corp (MDXHF) was upgraded to C- from D on 8/24/2018 due to a significant increase in the efficiency index, growth index and solvency index. Total revenue increased 75.84% from $178.8 to $314.4, and operating cash flow increased 18.74% from -$694.8 to -$564.6.
D
Sell 7/10/2018Downgrade
MedX Health Corp (MDXHF) was downgraded to D from D+ on 7/10/2018 due to a large decline in the total return index and volatility index.
D
Sell 6/5/2018Downgrade
MedX Health Corp (MDXHF) was downgraded to D+ from C on 6/5/2018 due to a significant decline in the efficiency index, total return index and growth index. Operating cash flow declined 144.91% from -$283.7 to -$694.8, EBIT declined 137.11% from -$212.6 to -$504.1, and net income declined 123.74% from -$237.6 to -$531.6.
C
Hold 5/2/2018Upgraded
MedX Health Corp (MDXHF) was upgraded to C from C- on 5/2/2018 due to a significant increase in the total return index, growth index and efficiency index. EBIT increased 49.59% from -$421.7 to -$212.6, earnings per share increased from -$0.0041 to -$0.0022, and net income increased 45.96% from -$439.7 to -$237.6.
C
Hold 11/2/2017Downgrade
MedX Health Corp (MDXHF) was downgraded to C- from C on 11/2/2017 due to a major decline in the total return index and volatility index.
C
Hold 9/25/2017Upgraded
MedX Health Corp (MDXHF) was upgraded to C from C- on 9/25/2017 due to a substantial increase in the total return index, growth index and solvency index. The quick ratio increased from 0.04 to 0.11, and debt to equity declined from -0.43 to -0.45.
C
Hold 9/15/2016Upgraded
MedX Health Corp (MDXHF) was upgraded to C- from D+ on 9/15/2016 due to a noticeable increase in the total return index and volatility index.
D
Sell 5/24/2016Downgrade
MedX Health Corp (MDXHF) was downgraded to D+ from C- on 5/24/2016 due to a decline in the volatility index.
C
Hold 5/2/2016Upgraded
MedX Health Corp (MDXHF) was upgraded to C- from D+ on 5/2/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 103.48% from -$356.2 to $12.4, total revenue increased 100.47% from $126.9 to $254.4, and earnings per share increased from -$0.0026 to -$0.0016.
D
Sell 4/12/2016Upgraded
MedX Health Corp (MDXHF) was upgraded to D+ from D on 4/12/2016 due to an increase in the volatility index, total return index and valuation index.
D
Sell 3/11/2016Downgrade
MedX Health Corp (MDXHF) was downgraded to D from C- on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
C
Hold 12/11/2015Upgraded
MedX Health Corp (MDXHF) was upgraded to C- from D+ on 12/11/2015 due to a noticeable increase in the efficiency index. Net income increased 342.48% from -$41.2 to -$182.3, and total capital increased 5.71% from -$1.28M to -$1.35M.
D
Sell 9/1/2015Upgraded
MedX Health Corp (MDXHF) was upgraded to D+ from D on 9/1/2015 due to a substantial increase in the valuation index, growth index and total return index. Total revenue increased 24.15% from $240.6 to $298.7, and EBIT increased 0.27% from -$36.6 to -$36.7.
D
Sell 3/2/2015Upgraded
MedX Health Corp (MDXHF) was upgraded to D from D- on 3/2/2015 due to an increase in the growth index, total return index and solvency index. The quick ratio increased from 0.03 to 0.05, and total revenue increased 34.39% from $201.8 to $271.2.
D
Sell 11/3/2014Upgraded
MedX Health Corp (MDXHF) was upgraded to D- from E+ on 11/3/2014 due to an increase in the growth index and solvency index. Debt to equity declined from -0.06 to -0.01, total revenue increased 41.12% from $143 to $201.8, and EBIT increased 25.44% from -$206.8 to -$259.4.
E
Sell 8/1/2014Upgraded
MedX Health Corp (MDXHF) was upgraded to E+ from E on 8/1/2014 due to a noticeable increase in the total return index, valuation index and efficiency index.
E
Sell 5/12/2014Upgraded
MedX Health Corp (MDXHF) was upgraded to E from on 5/12/2014 due to a significant increase in the efficiency index, solvency index and volatility index.
Weiss Ratings